Advertisement
YOU ARE HERE: LAT HomeCollectionsSchick Wilkinson Sword
IN THE NEWS

Schick Wilkinson Sword

FEATURED ARTICLES
BUSINESS
January 22, 2003 | From Bloomberg News
Energizer Holdings Inc. agreed to buy Pfizer Inc.'s Schick-Wilkinson Sword razor business for $930 million in cash as the No. 2 U.S. battery maker enters a second category to bolster declining sales. The purchase of Schick, maker of Xtreme 3 and Silk Effects, will help the company step up competition with larger rival Gillette Co., the maker of Mach3 and Venus razors and Duracell batteries. Shares of St. Louis-based Energizer fell $1.07 to $23.90 on the NYSE.
ARTICLES BY DATE
Advertisement
BUSINESS
August 13, 2003 | From Associated Press
The battle of the blades has abruptly sharpened, with Schick introducing the first four-blade razor and Gillette Co. countering hours later with a patent infringement suit against its rival. Schick-Wilkinson Sword, a unit of St. Louis-based Energizer Holdings, officially announced the Quattro, touting the $8.99 shaving system's design and synchronized blades.
BUSINESS
February 17, 2006 | From Reuters
Gillette and Schick-Wilkinson Sword have ended a long-running duel over patents and advertising claims, the world's two largest razor makers said Thursday. "Both companies have resolved the vast majority of litigation between them," a Gillette spokesman said. While the two "will remain competitors, we'll compete in the marketplace, not in the courtroom." A spokeswoman for Schick parent company Energizer Holdings Inc.
BUSINESS
September 15, 2005 | From Associated Press
Gillette Co. fired the latest shot in the blade wars Wednesday, introducing a new razor for men that features five blades, one more than competitor Schick's model. The razor, called Fusion, also has a facial hair trimmer on the back, the company said. The blades are 30% closer together, which the company says causes less irritation.
BUSINESS
April 23, 2003 | From Associated Press
Pfizer Inc.'s earnings soared in the first quarter because of solid pharmaceutical revenue and gains on businesses sold last year. But analysts expressed concern Tuesday that revenue from Pfizer's star drugs didn't grow as much as in previous quarters -- and in some cases declined in the U.S., the world's biggest pharmaceutical market. Meanwhile, Eli Lilly & Co. said one-time charges led to a 35% decline in its first-quarter earnings.
BUSINESS
November 4, 2004 | From Dow Jones/Associated Press
Orbitz Inc., the Internet travel agency that is being bought by Cendant Corp., posted a 30% jump in third-quarter profit, aided by a surge in hotel business. Chicago-based Orbitz said net income rose to $5.1 million, or 12 cents a share, from $3.9 million, or 10 cents a share, a year ago. The most recent quarter included several one-time items: a noncash charge of $1.4 million for restructuring; $4.2 million in expenses from the Cendant deal; and a $967,000 reversal of tax-related expenses.
Los Angeles Times Articles
|